Top Medical News
9 hours ago
Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.
Tristan Manalac, 10 hours ago
In foetuses exposed to the anti-Ro/SSA antibody, the rate of recurrence of conduction disturbances is higher than what was previously reported, according to a recent study. Moreover, the season of the year appears to be linked to atrioventricular (AV) time intervals during the congenital heart block risk period in such foetuses.
14 hours ago
Atrial fibrillation (AF) increases the risk of incident myocardial infarction (MI), according to a recent study from Korea. Moreover, the risk of AF-associated MI appears to be higher in patients without dyslipidaemia, ischaemic stroke, diabetes and hypertension.
Yesterday
Use of clarithromycin in the outpatient setting appears to be associated with long-term increases in mortality, a retrospective study has found. Additionally, erythromycin yields a similar, albeit smaller, increase in the said risk.
Yesterday
An association exists between proprotein convertase subtilisin/kexin type 9 (PCSK9)-low-density lipoprotein receptor (LDLR) axis and outcomes in patients with heart failure (HF), according to a recent study.
Yesterday
Left ventricular ejection fraction (LVEF), ischaemic cardiomyopathy and comorbidities are associated with all-cause mortality in patients receiving a primary prophylactic implantable cardioverter defibrillator (ICD), according to a recent study.
Roshini Claire Anthony, 3 days ago

Increasing evidence points to a link between hypertension and cognitive decline, particularly in the elderly population, according to a presentation at APCH 2017. However, the impact of antihypertensive medication use on dementia incidence is unestablished. 

Special Reports
Dr. Yeo Khung Keong, Dr. Wiwun Tungsubutra, Prof. Peter Collins, 31 Aug 2017
Agents such as beta-blockers and calcium antagonists have been the cornerstone of treatment for stable angina for some time. However, new options are emerging for patients who remain inadequately controlled on conventional therapies. At a recent Menarini-sponsored symposium held during the APSC Congress 2017 in Singapore, three experts discussed the current treatment landscape, as well as changing paradigms and new effective options for patients with symptomatic angina.
23 Aug 2017
Results from a survey presented at the 2017 Asia Pacific Society of Cardiology Congress indicate that 98% of respondents involved in managing patients with hypertension in Singapore recommend home blood pressure monitoring (HBPM) to patients with hypertension. However, a number of barriers remain to the effective use of out-of-office blood pressure (BP) monitoring.
Prof. Peter Collins, Prof. Giuseppe Mancia, Prof. Carolyn Lam, Dr. Choo Gim Hooi, 12 Jul 2017
Coronary artery disease (CAD) is the leading cause of death worldwide and is expected to remain so for the foreseeable future due to both the ageing population and the increasing prevalence of risk factors such as hypertension, dyslipidaemia, and diabetes. CAD is also the primary risk factor in the development of heart failure (HF). At the 2nd Asia Pacific CardioConnect Meeting in Hong Kong sponsored by Menarini, a group of international and regional experts discussed current strategies for managing stable CAD and HF and highlighted areas where patient outcomes may be improved.
25 May 2017
At a recent lunch symposium during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension, Dr Chow Yok Wai spoke on the importance of patient adherence in the management of hypertension, highlighting the role of combination therapy in improving treatment outcomes.
24 Apr 2017
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to treat pain and inflammation in patients with arthritis, but the vascular effects of some NSAIDs have cast doubt on whether they can be used in patients at risk for cardiovascular (CV) disease. At the American Heart Association’s Scientific Sessions 2016 held recently in New Orleans, Louisiana, US, Professor Steven Nissen of the Cleveland Clinic in Cleveland, Ohio, US, presented latest data from the PRECISION (Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen or Naproxen) trial that evaluated the CV risk and safety profile of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib vs nonselective NSAIDs.
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
07 Mar 2017
At the 17th Malaysian Society of Rheumatology/Singapore Society of Rheumatology Workshop, Associate Professor Susanna Proudman, a senior consultant in rheumatology from Australia, shared with the audience on the diagnosis and management of pulmonary arterial hypertension (PAH), with a focus on systemic sclerosis (SSc)-related PAH.
Conference Reports
Roshini Claire Anthony, 19 Oct 2017

Increasing evidence points to a link between hypertension and cognitive decline, particularly in the elderly population, according to a presentation at APCH 2017. However, the impact of antihypertensive medication use on dementia incidence is unestablished. 

Pearl Toh, 18 Oct 2017
For stroke prevention in an Asian population, a blood pressure (BP) of <140/90 mm Hg is a reasonable target and particularly, 120-130/80 mm Hg may be optimal, according to a presentation at the APCH 2017 Meeting in Singapore.
Stephen Padilla, 17 Oct 2017
Use of a Japanese nomogram in predicting hypertension cure in patients with primary aldosteronism (PA) is fairly accurate, and the achieved cure rate is similar to established series, according to a study presented at the 13th Asian-Pacific Congress of Hypertension (APCH 2017) held in Singapore.
Audrey Abella, 16 Oct 2017
The use of angiotensin converting enzyme (ACE) inhibitors may prevent repeat revascularization in patients who underwent percutaneous transluminal angioplasty (PTA) for peripheral artery disease (PAD) compared with angiotensin receptor blockers (ARB), according to a presentation at APCH 2017.
13 Oct 2017
Slideshow: Highlights from the 13th Asian-Pacific Congress of Hypertension (APCH)
Jairia Dela Cruz, 12 Oct 2017
A low-sodium meal plan aligned with the Dietary Approaches to Stop Hypertension (DASH) diet principles—which include more grains and vegetables and cut back on sugar and sweetened foods—has remarkable blood pressure (BP)-lowering effects, reducing systolic and diastolic BP by up to 8.9 and 4.5 mm Hg, respectively, according to Ms Quek Wei Lin, a dietitian who spoke at the 13th Asian-Pacific Congress of Hypertension (APCH 2017) in Singapore.
Tristan Manalac, 12 Oct 2017
Administration of a long-acting medication at the time that is most suitable for maximum patient compliance is the best approach in controlling blood pressure, said Dr. Trefor Morgan at the recently concluded 13th Asian-Pacific Congress of Hypertension (APCH 2017), held at the Suntec Singapore Convention and Exhibition Centre.
Product Highlights
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD